evobrutinib,ozanimod,natalizumab,ocrelizumab,ata-188
merck,bms,amgen,roche,atara biotherapeutics,biogen
['merck', 'biogen', 'bms', 'bristol', 'bmsnews']
 , , and others presented their latest data from ms programs at the 38th ectrims conference in amsterdam. #merck #bristolmyerssquibb #biogen ##ectrims2022 #biospace 
Your source for biopharma news and jobs